PREETI KOONER: Open Payments
NPI 1942960851 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,382 in 71 payments from 18 companies in 2025. Trend: 2023 $489 · 2024 $1,215 · 2025 $1,382
Food & beverage: $1,382
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 22 | $515 |
| Calliditas Therapeutics US Inc. | 17 | $205 |
| Amgen Inc. | 4 | $95 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $74 |
| Fresenius USA Marketing, Inc. | 4 | $68 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| Travere Therapeutics, Inc. | 2 | $56 |
| Vifor Pharma, Inc. | 2 | $46 |
| AKEBIA THERAPEUTICS INC | 2 | $43 |
| Novo Nordisk Inc | 2 | $42 |
Products named: IBSRELA, TARPEYO, XPHOZAH 30 MG, Kerendia, VELPHORO, KRYSTEXXA, Veltassa, Vafseo.
Industry payments across CA — which companies pay providers there.
